Connect with us

Health

Experimental drug combination extends survival in mice with lung cancer, study finds – News-Medical.Net

A combination of experimental drugs increased the attack of immune cells on non-small cell lung cancer (NSCLC) to extend survival…

Published

on

Article feature image

A combination of experimental drugs increased the attack of immune cells on non-small cell lung cancer (NSCLC) to extend survival in mice, a new study found.
Led by researchers at NYU Grossman School of Medicine and its Laura and Isaac Perlmutter Cancer…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending